Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest chemotherapy Stories

2013-09-23 12:42:42

Adding the chemotherapy drug cisplatin to a treatment plan of radiation therapy (RT) and high-dose-rate brachytherapy (HDRB) for stage IIIB cervical cancer is beneficial, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. The study also indicated that the combined treatments produced acceptable levels of toxicity. The randomized, controlled trial studied a total of 147 women in Brazil with stage IIIB squamous cell...

2013-09-21 08:20:20

World Premiere of "The Cause is the Cure" October 5 in Cities Nationwide ORLANDO, Fla., Sept. 21, 2013 /PRNewswire/ -- The trailer for the new short film, "The Cause is the Cure," was released today by Maximized Living, a multinational network of wellness doctors. The short film, which tells the true stories of people who have successfully overcome cancer diagnoses without chemotherapy or radiation, will premiere October 5 at more than 450 Maximized Living locations throughout the...

2013-09-20 23:04:18

The global market for cervical cancer drugs and diagnostics was valued at $11.3 billion in 2012 and is expected to reach $11.6 billion by 2013. BCC Research projects the market to reach nearly $15.6 billion by 2018, and register a compound annual growth rate (CAGR) of 6.1%. Wellesley, MA (PRWEB) September 20, 2013 According to a new technical market research report, Therapies and Diagnostics for Cervical Cancer from BCC Research (http://www.bccresearch.com), the global market for cervical...

Additive Found In Dog Food May Prevent A Disabling Chemotherapy Side Effect
2013-09-20 08:47:59

April Flowers for redOrbit.com - Your Universe Online A chemical commonly used as a dog food preservative might prevent the kind of painful nerve damage found in the hands and feet of four out of five cancer patients taking the chemotherapy drug Taxol. A team of Johns Hopkins researchers have been working with cells in test tubes and mice to investigate the Food and Drug Administration (FDA)-approved dog food preservative. The preservative, an antioxidant called ethoxyquin, has been...

2013-09-19 08:28:32

Studies from two major children's hospitals presented at the Association of Pediatric Hematology/Oncology Nurses (APHON) Annual Conference in Louisville, KY September 19-21 highlight the effectiveness of the ChemoClave closed system and closed system transfer device SAN CLEMENTE, Calif., Sept. 19, 2013 /PRNewswire/ -- ICU Medical, Inc. (NASDAQ: ICUI) today announced that two new studies presented this week at the 37(th) Annual Association of Pediatric Hematology/Oncology Nurses...

2013-09-18 23:32:43

Facing Chemo is an ongoing project by professional photographer, Robert Houser, that explores the simultaneous role in which chemotherapy patients both view themselves and are viewed by the outside world. San Francisco, CA (PRWEB) September 18, 2013 Bay area professional photographer, Robert Houser, presents Facing Chemo, a collection of images depicting the honest, unaffected emotions of people undergoing chemotherapy. The project began as a portrait session with a young woman about to...

2013-09-18 13:26:46

A team from the University of Rochester Medical Center has shown scientifically what many women report anecdotally: that the breast cancer drug tamoxifen is toxic to cells of the brain and central nervous system, producing mental fogginess similar to "chemo brain." However, in the Journal of Neuroscience, researchers also report they've discovered an existing drug compound that appears to counteract or rescue brain cells from the adverse effects of the breast cancer drug. Corresponding...

2013-09-18 08:30:02

SAN DIEGO, Sept. 18, 2013 /PRNewswire/ -- Once again she was told that she had only six months to live. C.W. Reed knew she had to act - fast. (Photo: http://photos.prnewswire.com/prnh/20130918/LA81487) The first time was four years ago, when she was diagnosed with stage 4 inflammatory breast cancer. As a practicing naturopath, C.W. was not ready to accept the side effects of chemotherapy and radiation. She agreed to surgery that involved removal of tumors from both breasts....

2013-09-17 04:22:19

CAMBRIDGE, England, September 17, 2013 /PRNewswire/ -- Acacia Pharma, a pharmaceutical company specialising in the development of drugs for supportive care, announces the initiation of two pivotal Phase 3 studies of APD421 in the prevention of post-operative nausea & vomiting (PONV). PONV remains a clinically significant problem in patients undergoing major surgery, despite the availability of a range of anti-emetic medications. The Phase 3 studies are taking place...

2013-09-16 08:28:10

PRINCETON, N.J., Sept. 16, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to the active ingredient SGX94 for the treatment of acute...


Latest chemotherapy Reference Libraries

Intravenous Therapy
2013-04-30 13:16:16

Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...

Antiviral Chemistry & Chemotherapy
2012-04-25 09:59:26

Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...

More Articles (2 articles) »